381 related articles for article (PubMed ID: 29439529)
1. Impact of DNA and RNA Methylation on Radiobiology and Cancer Progression.
Chi HC; Tsai CY; Tsai MM; Lin KH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29439529
[TBL] [Abstract][Full Text] [Related]
2. An Epigenetic Reprogramming Strategy to Resensitize Radioresistant Prostate Cancer Cells.
Peitzsch C; Cojoc M; Hein L; Kurth I; Mäbert K; Trautmann F; Klink B; Schröck E; Wirth MP; Krause M; Stakhovsky EA; Telegeev GD; Novotny V; Toma M; Muders M; Baretton GB; Frame FM; Maitland NJ; Baumann M; Dubrovska A
Cancer Res; 2016 May; 76(9):2637-51. PubMed ID: 26984757
[TBL] [Abstract][Full Text] [Related]
3. Epigenetics in radiotherapy: where are we heading?
Smits KM; Melotte V; Niessen HE; Dubois L; Oberije C; Troost EG; Starmans MH; Boutros PC; Vooijs M; van Engeland M; Lambin P
Radiother Oncol; 2014 May; 111(2):168-77. PubMed ID: 24861629
[TBL] [Abstract][Full Text] [Related]
4. DNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer: an outcome-predicting and treatment-implicating study.
Lin HY; Hung SK; Lee MS; Chiou WY; Huang TT; Tseng CE; Shih LY; Lin RI; Lin JM; Lai YH; Chang CB; Hsu FC; Chen LC; Tsai SJ; Su YC; Li SC; Lai HC; Hsu WL; Liu DW; Tai CK; Wu SF; Chan MW
Oncotarget; 2015 Jan; 6(2):915-34. PubMed ID: 25460508
[TBL] [Abstract][Full Text] [Related]
5. The pivotal role of DNA methylation in the radio-sensitivity of tumor radiotherapy.
Zhu X; Wang Y; Tan L; Fu X
Cancer Med; 2018 Aug; 7(8):3812-3819. PubMed ID: 29952116
[TBL] [Abstract][Full Text] [Related]
6. Methylation of promoter of RBL1 enhances the radioresistance of three dimensional cultured carcinoma cells.
Pan D; Chen Y; Du Y; Ren Z; Li X; Hu B
Oncotarget; 2017 Jan; 8(3):4422-4435. PubMed ID: 27779109
[TBL] [Abstract][Full Text] [Related]
7. The Critical Role of Hypoxic Microenvironment and Epigenetic Deregulation in Esophageal Cancer Radioresistance.
Macedo-Silva C; Miranda-Gonçalves V; Henrique R; Jerónimo C; Bravo I
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31739546
[TBL] [Abstract][Full Text] [Related]
8. Epigenetics as a determinant of radiation response in cancer.
Arechaga-Ocampo E
Int Rev Cell Mol Biol; 2024; 383():145-190. PubMed ID: 38359968
[TBL] [Abstract][Full Text] [Related]
9. Deciphering the epigenetic network in cancer radioresistance.
Cabrera-Licona A; Pérez-Añorve IX; Flores-Fortis M; Moral-Hernández OD; González-de la Rosa CH; Suárez-Sánchez R; Chávez-Saldaña M; Aréchaga-Ocampo E
Radiother Oncol; 2021 Jun; 159():48-59. PubMed ID: 33741468
[TBL] [Abstract][Full Text] [Related]
10. RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization.
Young A; Berry R; Holloway AF; Blackburn NB; Dickinson JL; Skala M; Phillips JL; Brettingham-Moore KH
BMC Cancer; 2014 Nov; 14():808. PubMed ID: 25369795
[TBL] [Abstract][Full Text] [Related]
11. Methylation of RASSF1A, RASSF2A, and HIN-1 is associated with poor outcome after radiotherapy, but not surgery, in oral squamous cell carcinoma.
Huang KH; Huang SF; Chen IH; Liao CT; Wang HM; Hsieh LL
Clin Cancer Res; 2009 Jun; 15(12):4174-80. PubMed ID: 19509163
[TBL] [Abstract][Full Text] [Related]
12. Prognostic relevance of miRNA-155 methylation in anaplastic glioma.
Schliesser MG; Claus R; Hielscher T; Grimm C; Weichenhan D; Blaes J; Wiestler B; Hau P; Schramm J; Sahm F; Weiß EK; Weiler M; Baer C; Schmidt-Graf F; Schackert G; Westphal M; Hertenstein A; Roth P; Galldiks N; Hartmann C; Pietsch T; Felsberg J; Reifenberger G; Sabel MC; Winkler F; von Deimling A; Meisner C; Vajkoczy P; Platten M; Weller M; Plass C; Wick W
Oncotarget; 2016 Dec; 7(50):82028-82045. PubMed ID: 27880937
[TBL] [Abstract][Full Text] [Related]
13. The potential of DNA modifications as biomarkers and therapeutic targets in oncology.
Jankowska AM; Millward CL; Caldwell CW
Expert Rev Mol Diagn; 2015; 15(10):1325-37. PubMed ID: 26394702
[TBL] [Abstract][Full Text] [Related]
14. Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents.
Oronsky B; Scicinski J; Kim MM; Cabrales P; Salacz ME; Carter CA; Oronsky N; Lybeck H; Lybeck M; Larson C; Reid TR; Oronsky A
Biomolecules; 2016 Jul; 6(3):. PubMed ID: 27384589
[TBL] [Abstract][Full Text] [Related]
15. Targeting cancer epigenetics: Linking basic biology to clinical medicine.
Shinjo K; Kondo Y
Adv Drug Deliv Rev; 2015 Dec; 95():56-64. PubMed ID: 26494398
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic gene regulation in cancer.
Ballestar E; Esteller M
Adv Genet; 2008; 61():247-67. PubMed ID: 18282509
[TBL] [Abstract][Full Text] [Related]
18. [Molecular mechanisms involved in epigenetic alterations in cancer].
Toyota M; Suzuki H; Nishizaka T; Sato A; Yamashita T
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1650-3. PubMed ID: 20841926
[TBL] [Abstract][Full Text] [Related]
19. Endoplasmic reticulum protein 29 (ERp29) confers radioresistance through the DNA repair gene, O(6)-methylguanine DNA-methyltransferase, in breast cancer cells.
Chen S; Zhang Y; Zhang D
Sci Rep; 2015 Sep; 5():14723. PubMed ID: 26420420
[TBL] [Abstract][Full Text] [Related]
20. DNA demethylating agents and epigenetic therapy of cancer.
Mani S; Herceg Z
Adv Genet; 2010; 70():327-40. PubMed ID: 20920754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
